- Home
- FI vs BSX Comparison
FI vs BSX Comparison
Compare FI & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FI
- BSX
- Stock Information
- Founded
- FI 1984
- BSX 1979
- Country
- FI United States
- BSX United States
- Employees
- FI N/A
- BSX N/A
- Industry
- FI Business Services
- BSX Medical/Dental Instruments
- Sector
- FI Consumer Discretionary
- BSX Health Care
- Exchange
- FI Nasdaq
- BSX Nasdaq
- Market Cap
- FI 124.0B
- BSX 129.7B
- IPO Year
- FI 1986
- BSX 1992
- Fundamental
- Price
- FI $206.09
- BSX $89.09
- Analyst Decision
- FI Buy
- BSX Strong Buy
- Analyst Count
- FI 25
- BSX 23
- Target Price
- FI $219.92
- BSX $96.41
- AVG Volume (30 Days)
- FI 3.2M
- BSX 4.6M
- Earning Date
- FI 02-04-2025
- BSX 01-29-2025
- Dividend Yield
- FI N/A
- BSX N/A
- EPS Growth
- FI 8.67
- BSX 47.19
- EPS
- FI 5.19
- BSX 1.21
- Revenue
- FI $20,122,000,000.00
- BSX $15,911,000,000.00
- Revenue This Year
- FI $3.48
- BSX $17.57
- Revenue Next Year
- FI $8.47
- BSX $12.29
- P/E Ratio
- FI $39.70
- BSX $73.58
- Revenue Growth
- FI 6.99
- BSX 15.66
- 52 Week Low
- FI $131.41
- BSX $55.60
- 52 Week High
- FI $223.23
- BSX $91.93
- Technical
- Relative Strength Index (RSI)
- FI 48.22
- BSX 46.40
- Support Level
- FI $201.61
- BSX $89.49
- Resistance Level
- FI $208.28
- BSX $91.59
- Average True Range (ATR)
- FI 4.01
- BSX 1.40
- MACD
- FI -1.08
- BSX -0.35
- Stochastic Oscillator
- FI 28.40
- BSX 23.79
About FI Fiserv Inc.
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Through the merger with First Data in 2019, Fiserv also provides payment processing services for merchants. About 10% of the company's revenue is generated internationally.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.